Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS)
CNY 3.63
(1.4%)
CNY 3.63
(1.4%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.78 Billion CNY | -1.76% |
| 2022 | 4.86 Billion CNY | -3.99% |
| 2021 | 5.06 Billion CNY | -3.03% |
| 2020 | 5.22 Billion CNY | -6.97% |
| 2019 | 5.61 Billion CNY | -13.24% |
| 2018 | 6.47 Billion CNY | -9.99% |
| 2017 | 7.19 Billion CNY | 9.19% |
| 2016 | 6.58 Billion CNY | 17.92% |
| 2015 | 5.58 Billion CNY | 1.67% |
| 2014 | 5.49 Billion CNY | 71.69% |
| 2013 | 3.2 Billion CNY | 40.58% |
| 2012 | 2.27 Billion CNY | 26.23% |
| 2011 | 1.8 Billion CNY | 15.26% |
| 2010 | 1.56 Billion CNY | 22.04% |
| 2009 | 1.28 Billion CNY | 5.2% |
| 2008 | 1.21 Billion CNY | 6.89% |
| 2007 | 1.14 Billion CNY | 15.42% |
| 2006 | 987.96 Million CNY | -17.67% |
| 2005 | 1.2 Billion CNY | 38.29% |
| 2004 | 867.79 Million CNY | 90.66% |
| 2003 | 455.14 Million CNY | 50.18% |
| 2002 | 303.06 Million CNY | 39.15% |
| 2001 | 217.8 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 4.4 Billion CNY | -6.37% |
| 2024 Q3 | 4.16 Billion CNY | -5.42% |
| 2024 Q1 | 4.7 Billion CNY | -1.56% |
| 2023 Q1 | 4.97 Billion CNY | 2.15% |
| 2023 Q3 | 4.9 Billion CNY | -1.97% |
| 2023 Q4 | 4.78 Billion CNY | -2.47% |
| 2023 FY | 4.78 Billion CNY | -1.76% |
| 2023 Q2 | 4.99 Billion CNY | 0.59% |
| 2022 Q2 | 5.81 Billion CNY | 10.5% |
| 2022 Q3 | 5.86 Billion CNY | 0.86% |
| 2022 Q4 | 4.86 Billion CNY | -17.06% |
| 2022 FY | 4.86 Billion CNY | -3.99% |
| 2022 Q1 | 5.26 Billion CNY | 3.86% |
| 2021 Q4 | 5.06 Billion CNY | -6.65% |
| 2021 Q3 | 5.42 Billion CNY | 3.32% |
| 2021 FY | 5.06 Billion CNY | -3.03% |
| 2021 Q2 | 5.25 Billion CNY | -1.67% |
| 2021 Q1 | 5.34 Billion CNY | 2.25% |
| 2020 FY | 5.22 Billion CNY | -6.97% |
| 2020 Q1 | 5.61 Billion CNY | -0.09% |
| 2020 Q2 | 5.52 Billion CNY | -1.66% |
| 2020 Q3 | 5.69 Billion CNY | 3.11% |
| 2020 Q4 | 5.22 Billion CNY | -8.17% |
| 2019 Q3 | 5.39 Billion CNY | -3.38% |
| 2019 Q2 | 5.58 Billion CNY | -2.58% |
| 2019 Q1 | 5.72 Billion CNY | -11.52% |
| 2019 FY | 5.61 Billion CNY | -13.24% |
| 2019 Q4 | 5.61 Billion CNY | 4.17% |
| 2018 Q3 | 7.46 Billion CNY | 1.11% |
| 2018 FY | 6.47 Billion CNY | -9.99% |
| 2018 Q4 | 6.47 Billion CNY | -13.26% |
| 2018 Q2 | 7.38 Billion CNY | -0.79% |
| 2018 Q1 | 7.44 Billion CNY | 3.44% |
| 2017 FY | 7.19 Billion CNY | 9.19% |
| 2017 Q1 | 6.8 Billion CNY | 3.33% |
| 2017 Q2 | 6.56 Billion CNY | -3.5% |
| 2017 Q3 | 6.92 Billion CNY | 5.39% |
| 2017 Q4 | 7.19 Billion CNY | 3.91% |
| 2016 Q3 | 6.46 Billion CNY | 9.17% |
| 2016 FY | 6.58 Billion CNY | 17.92% |
| 2016 Q1 | 5.59 Billion CNY | 0.2% |
| 2016 Q2 | 5.92 Billion CNY | 5.79% |
| 2016 Q4 | 6.58 Billion CNY | 1.91% |
| 2015 Q4 | 5.58 Billion CNY | 8.03% |
| 2015 Q2 | 4.96 Billion CNY | -6.43% |
| 2015 Q1 | 5.3 Billion CNY | -3.49% |
| 2015 FY | 5.58 Billion CNY | 1.67% |
| 2015 Q3 | 5.17 Billion CNY | 4.23% |
| 2014 FY | 5.49 Billion CNY | 71.69% |
| 2014 Q3 | 5.04 Billion CNY | 16.86% |
| 2014 Q4 | 5.49 Billion CNY | 9.0% |
| 2014 Q2 | 4.31 Billion CNY | 4.91% |
| 2014 Q1 | 4.11 Billion CNY | 28.49% |
| 2013 FY | 3.2 Billion CNY | 40.58% |
| 2013 Q4 | 3.2 Billion CNY | 21.47% |
| 2013 Q1 | 2.17 Billion CNY | -4.52% |
| 2013 Q2 | 2.37 Billion CNY | 9.36% |
| 2013 Q3 | 2.63 Billion CNY | 10.84% |
| 2012 Q4 | 2.27 Billion CNY | 13.51% |
| 2012 Q2 | 1.93 Billion CNY | 2.94% |
| 2012 Q1 | 1.87 Billion CNY | 4.09% |
| 2012 FY | 2.27 Billion CNY | 26.23% |
| 2012 Q3 | 2 Billion CNY | 3.78% |
| 2011 FY | 1.8 Billion CNY | 15.26% |
| 2011 Q4 | 1.8 Billion CNY | 14.02% |
| 2011 Q3 | 1.58 Billion CNY | 2.18% |
| 2011 Q2 | 1.54 Billion CNY | 1.44% |
| 2011 Q1 | 1.52 Billion CNY | -2.47% |
| 2010 FY | 1.56 Billion CNY | 22.04% |
| 2010 Q1 | 1.25 Billion CNY | -1.86% |
| 2010 Q2 | 1.39 Billion CNY | 10.79% |
| 2010 Q3 | 1.41 Billion CNY | 1.63% |
| 2010 Q4 | 1.56 Billion CNY | 10.45% |
| 2009 Q2 | 1.13 Billion CNY | 1.72% |
| 2009 Q4 | 1.28 Billion CNY | 2.16% |
| 2009 Q3 | 1.25 Billion CNY | 10.85% |
| 2009 Q1 | 1.11 Billion CNY | -8.68% |
| 2009 FY | 1.28 Billion CNY | 5.2% |
| 2008 Q4 | 1.21 Billion CNY | 9.84% |
| 2008 FY | 1.21 Billion CNY | 6.89% |
| 2008 Q1 | 1.09 Billion CNY | -4.08% |
| 2008 Q2 | 1.1 Billion CNY | 0.73% |
| 2008 Q3 | 1.1 Billion CNY | 0.71% |
| 2007 Q3 | 1.02 Billion CNY | -6.57% |
| 2007 Q1 | 1.02 Billion CNY | 3.56% |
| 2007 FY | 1.14 Billion CNY | 15.42% |
| 2007 Q2 | 1.09 Billion CNY | 7.04% |
| 2007 Q4 | 1.14 Billion CNY | 11.45% |
| 2006 Q2 | 1.09 Billion CNY | -7.09% |
| 2006 Q1 | 1.17 Billion CNY | -2.21% |
| 2006 Q4 | 987.96 Million CNY | -14.65% |
| 2006 FY | 987.96 Million CNY | -17.67% |
| 2006 Q3 | 1.15 Billion CNY | 6.16% |
| 2005 Q3 | 894.65 Million CNY | 2.39% |
| 2005 Q4 | 1.2 Billion CNY | 34.14% |
| 2005 Q1 | 841.51 Million CNY | -3.03% |
| 2005 FY | 1.2 Billion CNY | 38.29% |
| 2005 Q2 | 873.8 Million CNY | 3.84% |
| 2004 Q4 | 867.79 Million CNY | 16.63% |
| 2004 Q2 | 736.63 Million CNY | -4.69% |
| 2004 FY | 867.79 Million CNY | 90.66% |
| 2004 Q1 | 772.86 Million CNY | 69.81% |
| 2004 Q3 | 744.06 Million CNY | 1.01% |
| 2003 Q4 | 455.14 Million CNY | 0.0% |
| 2003 FY | 455.14 Million CNY | 50.18% |
| 2002 FY | 303.06 Million CNY | 39.15% |
| 2001 FY | 217.8 Million CNY | 0.0% |